← FDA Drug Approvals (Drugs@FDA)
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
NDA · New Drug Application · Sponsor: VANTIVE US HLTHCARE · Approved 2006-10-25
Drug application
- FDA Application #
NDA021703- Application type
- New Drug Application
- Brand name
- PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
- Generic name
- MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE
- Active ingredients
- CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- VANTIVE US HLTHCARE
- Manufacturer
- Vantive US Healthcare LLC
- First approval
- 2006-10-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown